Table 1.

Clinical characteristics of sJIA patients and healthy controls

Characteristics	Active sJIA (n = 23)	Inactiv sJIA (n = 23)	sJIA (n = 46)	HCs (n = 30)
Age (years)	7.3 ± 3.1	7.4 ± 3.3	7.4 ± 3.2	6.6 ± 2.8
Sex, no. F/M	13/10	7/16	20/26	12/18
Disease duration (years)	2.2 ± 0.88	2.0 ± 0.83	2.1 ± 0.86	N/A
JADAS-27	26.09 ± 7.48	13.94 ± 6.82	20.02 ± 9.37	N/A
ESR, mm/h	48.69 ± 5.64	35.77 ± 6.89	41.53 ± 9.69	N/A
CRP, mg/L	25.87 ± 6.17	21.47 ± 3.36	23.7 ± 4.43	N/A
PLT, 109/L	361.39 ± 91.94	350.22 ± 90.98	357.98 ± 90.37	N/A
ALT, U/L	20.07 ± 19.16	24.73 ± 20.72	22.41 ± 19.87	N/A
AST, U/L	33.32 ± 20.00	36.20 ± 18.97	34.76 ± 19.53	N/A
ANA positivity (%)	3 (13.04)	0 (0)	3 (6.52)	N/A
RF positivity (%)	0 (0)	0 (0)	0 (0)	N/A

For age, disease duration, JADAS-27, ESR, CRP, PLT, ALT and AST, data are presented as median

N/A, not available